πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,063 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8846057

Recombinant live attenuated foot-and-mouth disease (FMD) vaccine containing mutations in t

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8846389

AAV4 vector and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8846051

Modulation of replicative fitness by deoptimization of synonymous codons

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8846055

Virulence determinant within the E2 structural glycoprotein of classical swine fever virus

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8846056

Anti-RSV immunogens and methods of immunization

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control Β· Granted Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8841266

Pharmaceutical composition and method for regulating abnormal cellular proliferation

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer Β· Granted Tue Sep 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8841305

Activators of the human pyruvate kinase M2 receptor

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8835167

Humanized anti-tag 72 CC49 for diagnosis and therapy of human tumors

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Sep 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8835378

Multi-domain amphipathic helical peptides and methods of their use

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Sep 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8835613

Ξ²-mannosylceramide and stimulation of NKT cell anti-tumor immunity

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8828936

Therapeutic use of SCGB3A2

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8829022

N-substituted indenoisoquinolines and syntheses thereof

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Sep 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8828380

Method for the treatment of pulmonary disease and method of producing proteins of use ther

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8828717

Framework residue substituted humanized COL-1 antibodies and their use

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Sep 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8828356

Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosc

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Sep 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8821866

Methods of treating and preventing colitis involving IL-13 and NK-T cells

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8822192

Human rotavirus vaccine strains and diagnostics

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Sep 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8822196

Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of s

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8822540

Nitisinone for treatment of oculocutaneous/ocular albinism and for increasing pigmentation

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8822434

Compositions and methods to treat cardiac diseases

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8815229

Granulysin in immunotherapy

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 26 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8816059

Method for predicting and detecting tumor metastasis

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 26 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8809502

Mutated anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Aug 19 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8808684

Epidermal growth factor receptor (EGFR) and methods of use in adenoviral-associated virus

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 19 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted